Provided by Tiger Trade Technology Pte. Ltd.

Onconetix Inc.

0.6634
+0.01822.82%
Post-market: 0.67580.0124+1.88%19:58 EDT
Volume:129.35K
Turnover:85.90K
Market Cap:2.62M
PE:-0.25
High:0.6900
Open:0.6390
Low:0.6390
Close:0.6452
52wk High:209.50
52wk Low:0.5859
Shares:3.95M
Float Shares:3.69M
Volume Ratio:0.37
T/O Rate:3.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6880
EPS(LYR):-828.1488
ROE:-105.23%
ROA:-27.03%
PB:0.19
PE(LYR):0.00

Loading ...

Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation

THOMSON REUTERS
·
Jul 07

Onconetix Says Realbotix Acquisition Closing Expected in H2 2026

Reuters
·
Jun 24

Onconetix - Registers up to 100 Mln Shares for Resale by Keystone Capital Partners - SEC Filing

THOMSON REUTERS
·
Jun 09

Press Release: Realbotix Reports Financial Results for Q2-2026

Dow Jones
·
May 29

Realbotix swings to Q2 FY26 profit of USD 442,375; revenue falls to USD 225,000

Reuters
·
May 29

Oncopeptides Accelerates CEE Expansion for Pepaxti via Exclusive Salus Distribution Deal

TIPRANKS
·
May 26

Onconetix Inc trading halted, news pending

TIPRANKS
·
May 21

BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy

Reuters
·
May 19

BRIEF-Onconetix, Inc. Announces 1-For-10 Reverse Stock Split

Reuters
·
May 19

BRIEF-Realbotix Provides Update On Nasdaq Listing

Reuters
·
May 19

Onconetix, Inc. Announces 1-for-10 Reverse Stock Split

THOMSON REUTERS
·
May 19

Realbotix says Nasdaq reverse takeover listing for unit expected to close by October 2026

Reuters
·
May 19

Realbotix Corp - to Retain 75–90% Ownership of Realllc After Nasdaq Listing

THOMSON REUTERS
·
May 19

Onconetix (ONCO) Stock Surges Over 23% Overnight: Why Is It Moving?

Benzinga Earnings
·
May 19

Onconetix Q1 EPS $(6.71) Up From $(225.25) YoY, Sales $21.457K Down From $101.630K YoY

Benzinga Earnings
·
May 13

Onconetix unit Proteomedix launches Proclarix U.S. validation study with Labcorp

Reuters
·
May 13

Onconetix Q1 net loss narrows 50.7% to $4.21 million

Reuters
·
May 13

Oncopeptides showcases new Pepaxti data to bolster multiple myeloma positioning

TIPRANKS
·
May 13

Oncopeptides posts strong Q1 sales growth as Pepaxti momentum builds in Europe

TIPRANKS
·
May 13

Onconetix:Prospectus Relates to Offer & Sale From Time to Time by Keystone Capital Partners of up to 25 Mln Shares of Common Stock of Co

THOMSON REUTERS
·
May 12